Approval · Notice of Compliance 8659 · 2007
PERINDOPRIL: Notice of Compliance 8659
Issued March 20, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8659
- Date
- March 20, 2007
- Company
- Proval Pharma Division Of Servier Canada IncLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PERINDOPRIL | 02292955 | — |
| PERINDOPRIL | 02292963 | — |
| PERINDOPRIL | 02292971 | — |
Medicinal ingredients
- PERINDOPRIL ERBUMINE 2 MG per TAB
- PERINDOPRIL ERBUMINE 4 MG per TAB
- PERINDOPRIL ERBUMINE 8 MG per TAB